Darrell R. Borger PhD

Dr. Darrell Borger aspirations have been to find and develop avenues that assure the latest concepts and the very best therapies are delivered to cancer patients for the treatment of their disease. Borger firmly believe this is best attained through the development of closely integrated teams that combine expertise across technology, tumor biology, preclinical modeling, bioinformatics, drug development, clinical development, and clinical implementation. At the Massachusetts General Hospital, Borger have provided a direct conduit to deliver a precision medicine approach to patients. At Takeda, Borger privileged to be part of a world-renowned team to develop cutting-edge and best-in-class therapies, particularly as it relates to immunotherapy.